How should we measure informed choice? The case of cancer screening
Share this article
Click the icon of the social media platform on which you would like to share this article.
Email this article to a friend
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Other content recommended for you
- Understanding risk and lessons for clinical risk communication about treatment preferences
- “Informed choice” in a time of too much medicine—no panacea for ethical difficulties
- Randomised trial to evaluate the effectiveness and impact of offering postvisit decision support and assistance in obtaining physician-recommended colorectal cancer screening: the e-assist: Colon Health study—a protocol study
- Screening for cardiovascular risk: public health imperative or matter for individual informed choice?
- What do European women know about their female cancer risks and cancer screening? A cross-sectional online intervention survey in five European countries
- Psychological correlates of free colorectal cancer screening uptake in a Scottish sample: a cross-sectional observational study
- Effect of evidence based risk information on “informed choice” in colorectal cancer screening: randomised controlled trial
- Concerns, perceived need and competing priorities: a qualitative exploration of decision-making and non-participation in a population-based flexible sigmoidoscopy screening programme to prevent colorectal cancer
- Infant hearing screening: route to informed choice
- A decision aid to support informed choices about bowel cancer screening among adults with low education: randomised controlled trial